GoodRx Stock (NASDAQ:GDRX)


ForecastRevenueOwnershipFinancialsChartTranscripts

Previous Close

$2.56

52W Range

$1.77 - $5.81

50D Avg

$2.50

200D Avg

$2.91

Market Cap

$911.64M

Avg Vol (3M)

$1.62M

Beta

1.61

Div Yield

-

GDRX Company Profile


GoodRx Holdings, Inc. provides American consumers with essential resources and tools to compare and ultimately lower the cost of their prescription medications. The company operates a digital platform dedicated to price comparison, delivering customized, geographically tailored prescription pricing. It also grants access to special, negotiated rates through unique GoodRx codes, which can be utilized for savings on prescriptions throughout the entire United States. Beyond this core offering, the firm also extends its portfolio to include subscription services, programs designed for pharmaceutical manufacturers, and telehealth capabilities. GoodRx additionally collaborates with pharmacy benefit managers, entities responsible for managing drug formularies and overseeing prescription transactions, including the critical task of setting prices between consumers and pharmacies. The company was founded in 2015 and maintains its principal office in Santa Monica, California.

Show More

Industry

Medical - Healthcare Information Services

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

738

IPO Date

Sep 23, 2020

Website

GDRX Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 24Dec 23Dec 22
Subscription Revenue$86.54M$94.41M$96.17M
Prescription Transactions Revenue$577.55M$550.74M$550.54M
Other Revenue$21.00M$20.05M$20.43M

Fiscal year ends in Dec 24 | Currency in USD

GDRX Financial Summary


Dec 24Dec 23Dec 22
Revenue$792.32M$750.26M$766.55M
Operating Income$65.85M$-27.01M$11.01M
Net Income$46.53M$-8.87M$-32.83M
EBITDA$48.08M$108.82M$68.54M
Basic EPS$0.12$-0.02$-0.08
Diluted EPS$0.12$-0.02$-0.08

Fiscal year ends in Dec 24 | Currency in USD

Latest Earnings Call Transcripts


Q1 26May 08, 26 | 12:00 AM
Q4 25Feb 26, 26 | 8:00 AM
Q3 25Nov 05, 25 | 8:00 AM

Peer Comparison


TickerCompany
LFMDLifeMD, Inc.
CTEVClaritev Corporation
INVAInnoviva, Inc.
AMPHAmphastar Pharmaceuticals, Inc.
AHCOAdaptHealth Corp.
MDXGMiMedx Group, Inc.
PLSEPulse Biosciences, Inc.
HSTMHealthStream, Inc.
IRMDIRadimed Corporation
COLLCollegium Pharmaceutical, Inc.